Renalase in hypertension and kidney disease
Authors:
Open Access
- 17 October 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 29 (1) , 22-28
Abstract
Renalase, a recently discovered flavoprotein, which is strongly expressed in the kidney and heart, effectively metabolizes catecholamines. It was discovered during the search to identify proteins secreted by the kidney that could help explain the high incidence of cardiovascular disease in patients with chronic kidney disease. Recent advances have led to more detailed knowledge of its biology, structure, enzymatic activity, mechanisms of action, associations with human disease states and potential therapeutic value. In this study, we review these advances with a focus on hypertension and kidney disease.Keywords
This publication has 31 references indexed in Scilit:
- Renalase Lowers Ambulatory Blood Pressure by Metabolizing Circulating AdrenalineJournal of the American Heart Association, 2012
- Renalase, a Novel Enzyme Involved in Blood Pressure Regulation, Is Related to Kidney Function but Not to Blood Pressure in Hemodialysis PatientsKidney and Blood Pressure Research, 2012
- Renalase Gene Polymorphisms in Patients With Type 2 Diabetes, Hypertension and StrokeNeuroMolecular Medicine, 2011
- FAD-Binding Site and NADP Reactivity in Human Renalase: A New Enzyme Involved in Blood Pressure RegulationJournal of Molecular Biology, 2011
- Increased renal dopamine and acute renal adaptation to a high-phosphate dietAmerican Journal of Physiology-Renal Physiology, 2011
- Renalase Deficiency in Heart Failure Model of Rats—A Potential Mechanism Underlying Circulating Norepinephrine AccumulationPLOS ONE, 2011
- A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul StudyPLOS ONE, 2010
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesNature Genetics, 2009
- Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytesBiochemical Journal, 2006
- Epinephrine enhances neurogenic vasoconstriction in the rat perfused kidney.Hypertension, 1985